Variant report
Variant | esv2830152 |
---|---|
Chromosome Location | chr5:27611431-27632765 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75446062 | chr5:27619441-27619442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10940680 | chr5:27619470-27619471 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs552812238 | chr5:27619505-27619506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536253433 | chr5:27619518-27619519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536196084 | chr5:27619524-27619525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555054037 | chr5:27619578-27619579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187584392 | chr5:27619599-27619600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112070443 | chr5:27619602-27619603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566330784 | chr5:27619700-27619701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576447674 | chr5:27619729-27619730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191654416 | chr5:27619743-27619744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558864936 | chr5:27619746-27619747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34906954 | chr5:27619756-27619757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147517839 | chr5:27619799-27619800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114042180 | chr5:27619831-27619832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373006034 | chr5:27619869-27619870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529717578 | chr5:27619874-27619875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184091567 | chr5:27619957-27619958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548542944 | chr5:27619960-27619961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568336145 | chr5:27620002-27620003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189703814 | chr5:27620019-27620020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552383143 | chr5:27620030-27620031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138449439 | chr5:27620081-27620082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192707311 | chr5:27620086-27620087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537063071 | chr5:27620116-27620117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528241777 | chr5:27620160-27620161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141687541 | chr5:27620181-27620182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150523455 | chr5:27620207-27620208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139512916 | chr5:27620217-27620218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184508901 | chr5:27620225-27620226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs55915220 | chr5:27620259-27620260 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs77309964 | chr5:27620352-27620353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537137405 | chr5:27620384-27620385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558976850 | chr5:27620386-27620387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs61653870 | chr5:27620392-27620393 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs190467616 | chr5:27620399-27620400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545224428 | chr5:27623819-27623820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12188986 | chr5:27623823-27623824 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs527845611 | chr5:27623903-27623904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115926823 | chr5:27624016-27624017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561380713 | chr5:27624068-27624069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531376782 | chr5:27624079-27624080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549508392 | chr5:27624082-27624083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552144624 | chr5:27624088-27624089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35736853 | chr5:27624159-27624160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571389677 | chr5:27624220-27624221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538719610 | chr5:27624244-27624245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547479568 | chr5:27624245-27624246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147103630 | chr5:27624246-27624247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565965482 | chr5:27624249-27624250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:27619400-27620400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr5:27620000-27620400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr5:27620200-27620400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr5:27623800-27626200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |